Idexx Laboratories, Inc’s filing revealed that its Director JUNIUS DANIEL M unloaded Company’s shares for reported $1.36 million on May 13 ’25. In the deal valued at $506.41 per share,2,683 shares were sold. As a result of this transaction, JUNIUS DANIEL M now holds 3,304 shares worth roughly $1.71 million.
Then, JUNIUS DANIEL M bought 2,683 shares, generating $1,358,697 in total proceeds.
Before that, Vandebroek Sophie V. sold 1,279 shares. Idexx Laboratories, Inc shares valued at $628,425 were divested by the Director at a price of $491.34 per share. As a result of the transaction, Vandebroek Sophie V. now holds 1,167 shares, worth roughly $0.6 million.
Leerink Partners initiated its Idexx Laboratories, Inc [IDXX] rating to an Outperform in a research note published on December 02, 2024; the price target was $500. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Piper Sandler also remained covering IDXX and has decreased its forecast on January 30, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Exane BNP Paribas started covering the stock on December 07, 2023. It rated IDXX as “an Outperform”.
Price Performance Review of IDXX
On Tuesday, Idexx Laboratories, Inc [NASDAQ:IDXX] saw its stock fall -0.87% to $517.16. Over the last five days, the stock has gained 1.58%. Idexx Laboratories, Inc shares have risen nearly 25.09% since the year began. Nevertheless, the stocks have fallen -4.40% over the past one year. While a 52-week high of $545.43 was reached on 05/20/25, a 52-week low of $356.14 was recorded on 04/09/25. SMA at 50 days reached $437.19, while 200 days put it at $448.87.
Levels Of Support And Resistance For IDXX Stock
The 24-hour chart illustrates a support level at 512.90, which if violated will result in even more drops to 508.64. On the upside, there is a resistance level at 522.45. A further resistance level may holdings at 527.74. The Relative Strength Index (RSI) on the 14-day chart is 75.90, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 22.03, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 10.29%. Stochastics %K at 96.44% indicates the stock is a selling.
